BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38180299)

  • 1. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
    Liang PI; Wei YC; Chen HD; Ma YC; Ke HL; Chien CC; Chuang HW
    Kaohsiung J Med Sci; 2024 Mar; 40(3):269-279. PubMed ID: 38180299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
    Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
    BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
    Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
    Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
    Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
    Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
    Chan TC; Pan CT; Hsieh HY; Vejvisithsakul PP; Wei RJ; Yeh BW; Wu WJ; Chen LR; Shiao MS; Li CF; Shiue YL
    Cell Oncol (Dordr); 2023 Aug; 46(4):933-951. PubMed ID: 36920729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.
    Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF
    J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654
    [No Abstract]   [Full Text] [Related]  

  • 11. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
    World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer.
    Mir MA; Pandith AA; Mansoor S; Baba SM; Makhdoomi R; Ain QU; Anwar I; Para SA; Bhat AH; Koul AM; Manzoor U; Khan I; Beg A; Wani MS
    Gene; 2023 Aug; 878():147583. PubMed ID: 37353040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder.
    He HL; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Kuo YH; Shiue YL; Li CF
    World J Surg Oncol; 2023 Feb; 21(1):62. PubMed ID: 36841776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
    Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
    World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis.
    Li WM; Chan TC; Wei YC; Li CF; Ke HL; Wu WJ; Hsu CC; Wang SC; Yeh CF
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):217. PubMed ID: 37796703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.
    Yates DR; Catto JW
    World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.
    Kao CC; Chang YL; Liu HY; Wu ST; Meng E; Cha TL; Sun GH; Yu DS; Luo HL
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
    Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.
    Nishiyama N; Kita Y; Ito K; Kato M; Hatakeyama S; Matsushita Y; Naito S; Miyake M; Nakanishi S; Kato Y; Shibuya T; Hayashi T; Yasumoto H; Yoshida T; Uemura M; Taoka R; Nishiyama H; Kobayashi T; Kitamura H;
    Anticancer Res; 2023 Nov; 43(11):5041-5050. PubMed ID: 37909969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
    Chen CY; Liao YM; Tsai WM; Kuo HC
    J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.